7 results
8-K
EX-99.1
ACRS
Aclaris Therapeutics Inc
14 Apr 23
Regulation FD Disclosure
7:11am
Therapeutics, Inc. Leadership Scientific Discovery led by World Class Kinase Expertise Kinome experts skilled at developing novel kinase targeted
8-K
EX-99.1
ACRS
Aclaris Therapeutics Inc
7 Dec 21
Regulation FD Disclosure
7:01am
skilled at developing kinase targeted medicines Biopharmaceutical Company Focused on the Kinome: People + Platform + Pipeline KINect® PLATFORM
8-K
EX-99.1
ACRS
Aclaris Therapeutics Inc
19 Jan 21
Regulation FD Disclosure
7:15am
by Physicians and Scientists World class ex-Pfizer (kinase) and ex-GSK (immunology) leadership Kinome experts skilled at developing kinase targeted
8-K
EX-99.1
ACRS
Aclaris Therapeutics Inc
15 Sep 20
Regulation FD Disclosure
7:05am
by Physicians and Scientists World class ex-Pfizer (kinase) and ex-GSK (immunology) leadership Kinome experts skilled at developing kinase targeted medicines
8-K
EX-99.1
yckvsk czjyc6et8frgi
27 May 20
Regulation FD Disclosure
7:03am
- Prev
- 1
- Next